Senior Medical Device Sales Executive, Human Factors

Repligen Corporation; País Vasco; Hybrid; EUR 142,000 - 196,000; Full time

Job summary

Emergo by UL seeks a Senior Sales Executive for Human Factors advisory services in the EMEA region. The role is customer-facing, closing premium HF engagements, and requires deep technical credibility in medical and life sciences markets.

The position supports remote or hybrid work from Barcelona, Basingstoke, or The Hague, with travel up to 30% and a strong focus on expanding the HF services portfolio.

Qualifications

• 5+ years of consultative sales experience and proven ability to meet and exceed sales targets (minimum $3 million/year)
• Medical device and/or life sciences industry experience required
• Bachelor's and/or graduate degree in business, human factors engineering, biomedical engineering, life science or related field
• English proficiency at least C1 level
• Ability to travel including client visits and trade shows up to 30%

Responsibilities

• Serve as primary contact for HF advisory services throughout the sales cycle
• Articulate value proposition in client presentations and proposals
• Develop and close customized advisory service solutions
• Develop sales pipeline via outreach and trade shows/conferences
• Build trust with customers to identify needs and pain points
• Advise leadership on evolving customer needs and industry trends
• Maintain plan to prioritize target accounts and relationships

Skills

Consultative sales

Relationship building

Industry knowledge (medical devices)

English proficiency (C1)

Travel readiness

Education

Bachelor's degree or higher

Tools

CRM software

MS Office

Job description

Emergo by UL seeks a Senior Sales Executive for Human Factors advisory services in the EMEA region. The role is customer-facing, closing premium HF engagements, and requires deep technical credibility in medical and life sciences markets.

The position supports remote or hybrid work from Barcelona, Basingstoke, or The Hague, with travel up to 30% and a strong focus on expanding the HF services portfolio.